Kinarus Therapeutics Holding Ag Is A Clinical Stage Biopharmaceutical Company Based In Baselswitzerlandfounded In 2017The Company Focused On Developing Innovative Therapies For Viralrespiratoryand Ophthalmic Diseasesits Lead Candidatekin001Is A Combinatorial Therapeutic Designed For Oral Administrationtargeting Inflammatoryfibroticand Viral Conditionskinarus Advanced Kin001 Through Clinical Trials For Conditions Such As Covid 19 Pneumonia And Fibrotic Eye Disorders The Company Specialized In Patient Oriented Treatmentsparticularly For Diseases That Affect Quality Of Lifekinarus Also Developed Patented Methods For Treating Retinal Disordersincluding Diabetic Macular Edema And Retinal Fibrosisthe Company Held Three Patentswith One Granted In 2023 For Ophthalmic Disease Treatments
No conferences found for this company.
| Company Name | Curatis Pharma Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
